Experimental 'stapled peptide' drug blocks key cancer molecule

Experimental 'stapled peptide' drug blocks key cancer molecule

(Medical Xpress)—US scientists have developed an artificial molecule called a 'stapled peptide' that can shut down the cancer-fuelling effects of a molecule called Wnt. 

The peptide has so far only been tested in mice, but "may serve as a prototype " for patients, according to the researchers from Harvard Medical School. 

Wnt is part of a molecular signalling network that controls several normal . But this system of regulating the cell can go awry and lead to cancer. 

Faults in Wnt signalling are found in many cancers, particularly

The new peptide mimics the structure of a naturally occurring molecule called BCL9, which is necessary to transmit signals sent by Wnt in , but not in healthy cells. 

Because of its similarity to BCL9, the stops signals being sent, shutting off the cancer-driving signals inside cancer cells. 

Commenting on the US team's findings, Dr Mariann Bienz, a Cancer Research UK scientist from the MRC Laboratory of in Cambridge, said that scientists have been trying to find ways to block Wnt or the molecules it interacts with for several years. 

She said: "One of the biggest challenges in cancer research is finding ways to disarm the molecules that fuel the disease, and blocking the interaction between proteins inside cells is notoriously difficult. This work builds on ours and other groups, and shows that it's possible to block the cancer-promoting interaction between BCL9 and beta-catenin, two key proteins in the Wnt signalling pathway. 

"The technology they've used – called stapled peptides – is very interesting, and could be used against other molecules that are currently considered 'undruggable'." 

She also said that significant challenges remain. Scientists do not yet know whether stapled peptides-based treatments can effectively reach their targets inside cells, nor how they are processed by the body. 

"But this is a very active area of research, and it will be exciting to see where it leads," she added. 

More information: Takada, K. et al. (2012). Targeted Disruption of the BCL9/ -Catenin Complex Inhibits Oncogenic Wnt Signaling, Science Translational Medicine, 4 (148) 148ra117. DOI: 10.1126/scitranslmed.3003808

Related Stories

Regulation of telomerase in stem cells and cancer cells

date Jun 27, 2012

Scientists at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg have gained important insights for stem cell research which are also applicable to human tumours and could lead to the development of new ...

Researchers identify breast cancer culprits

date Aug 17, 2010

Scientists have discovered an accomplice in breast cancer - a master control switch with the power to set off a cascade of reactions orchestrated by a cancer-causing gene (or oncogene) named Wnt1. This executive molecule ...

Mechanism regulates protein stability in cells

date Jan 04, 2011

(PhysOrg.com) -- A cell-signaling pathway known as Wnt, which is commonly activated in cancers, causes membranes within a healthy cell to imprison an enzyme that is vital in degrading proteins, preventing ...

Recommended for you

Study finds new potential melanoma drug target

date May 02, 2015

A new treatment for melanoma could be on the horizon, thanks to a finding by a UNC Lineberger Comprehensive Cancer Center-led team. In the study, which was published online today in the journal Clinical Ca ...

Surgery for terminal cancer patients still common

date May 02, 2015

The number of surgeries performed on terminally ill cancer patients has not dropped in recent years, despite more attention to the importance of less invasive care for these patients to relieve symptoms and ...

Study provides comprehensive look at brain cancer treatments

date May 01, 2015

Led by the Translational Genomics Research Institute (TGen) and UC San Francisco (UCSF), a comprehensive genetic review of treatment strategies for glioblastoma brain tumors was published today in the Oxford University Press ...

How artificial tanning can lead to melanoma

date May 01, 2015

Young women may be up on the latest fashions and trends as they prepare for prom season. But what many don't know is that the tan that looks oh-so-good with their dress may be the first step toward skin cancer.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.